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ABSTRACT 
Cardiovascular disease (CVD) is a disorder of heart and blood vessels. CVD is one of the major causes of deaths in India, which contributed 
around 30 to 40%. The aim of the study was to study the prescribing pattern of drugs, identification of drug related problems and 
therapeutic intervention in CVD patients. A hospital based prospective and observational study was carried out for a period of nine months 
in a south Indian tertiary care hospital. Among 120 selected patients, 79 were male  (65.83%) and 41 were female  (34.16%), more number 
of patients (35) were between the age group of 55-64 (29.16%) of which 27 were males & 8 were females, and very less number of patients 
(6) were between the age group 85-94 (5%) of which all the 6 were male. Hypertension is the most commonest and dominant disorder, 
which affected 47(39.16%) patients, in which 30 were male (25%) and 17 were female (14.16%). Most common risk factor is HTN followed 
with smoking and diabetes of 45 patients (37.5%). The most often prescribed pattern adopted in CVD is Dual therapy, it is most frequently 
used therapy 50 (41.66%) and quadruple therapy is less frequently 6(6.5%) used. The diuretics and calcium channel blocker combination 
were maximally prescribed class of drugs as a dual therapy. A total of 47 drug-drug interactions were found, among 12 were major, 15 were 
moderate and 20 were minor interactions. Clinical pharmacist has intervened with the help of other health care professionals in order to 
reduce the risk factor and minimise the drug-drug interactions. The study provides the benefits of presence of clinical pharmacist in a 
hospital setting, in order to prevent the medication related errors and provide the expertise pharmacotherapy opinion in CVD patients, 
which improves the patient compliance.  Hence study justifies a need of active collaboration between clinical pharmacist, physician and 
other health care professionals for the better management of CVD patients. 
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INTRODUCTION 
CVD is a class of diseases which affect the heart, blood 
vessels and  circulatory system,  the commonest form of 
CVD are, coronary heart disease (CHD), congestive heart 
failure (CHF), stroke, hypertension, peripheral artery 
disease, and rheumatic heart disease.1 Cardiovascular 
disease is one of the major causes of deaths. The 
percentage of deaths in India due to cardiovascular 
disorders was estimated to be 30-40%.2Typical symptoms 
of an underlying CVD includes pain or pressure in the 
chest, shortness of breath, irregular heart beat pain or 
discomfort in the arms ,left shoulder, elbows, jaw or back, 
nausea and fatigue, light headed or faint ,cold sweat.3 The 
CVD is caused by two types of risk factors i.e. Modifiable 
and Non modifiable risk factors like hypertension, 
diabetes, smoking, physical inactivity,  unhealthy diet, 
cholesterol/lipids, over weight and obesity, lack of sleep, 
age, family history.4 A number of different tests are used to 
diagnose the heart-related problems including, blood tests, 
coronary angiography, Electrocardiogram (ECG), exercise 
stress tests, X-rays, Echocardiogram ,Radionuclide tests,  
Magnetic Resonance imaging (MRI) scans, Computerised 
Tomography (CT) scans. CVD can be effectively treated 
with a combination of lifestyle changes, medicines and in 
some cases surgery. There are various medications used 
for the treatment of CVD that may either aim to widen the 
arteries or to lower the blood pressure.5 Most common 
classes of drugs prescribed in CVD patients includes Anti-
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platelets that  inhibit platelet function by blocking 
cyclooxygenase and subsequent aggregation.eg :low dose 
aspirin, prasugrel, clopidogrel.6 Statins act by blocking 
cholesterol formation and increasing the number of low 
density lipoprotein (LDL) receptors in the liver.eg : 
Atorvastatin, rosuvastatin.7 Beta blockers- they work by 
blocking the effect of specific harmone in the body that 
slows down heart beat which helps to increase blood 
flow.eg: atenolol, metoprolol.8 Nitrates are used for 
vasodilation. Eg: ISMN, ISDN.9ACE inhibitors are used to 
treat high blood pressure. Eg: Ramipril, esinopril. 
Angiotensin II receptor antagonist works similar to ACE 
inhibitors by blocking angiotensin II receptors.10 Calcium 
channel blockers works to widen the arteries and 
reduction of blood pressure.eg: Amlodipine, diltiazem.11 
Diuretics works by removing excess water and salt from 
the body via urine.eg: Spirinolactone.12 Surgical methods 
include coronary angioplasty, coronary artery bypass 
graft(CABG), Heart transplant.13Clinical pharmacist plays 
an important role in reducing the risk factors, drug-drugs 
interactions and drug related problems. The study 
provides the benefits of the presence of clinical pharmacist 
in a hospital setting, in order to prevention of medication 
errors; provide the expertise pharmacotherapy and better 
management of drug therapy based on patients specific 
factors.  All together influence the improvement in patient 
compliance, safety, level of care, better control of risk 
factor and health care cost and ultimately results in overall 
development of patients quality of life. 
MATERIALS AND METHODS 
Study design and settings: A prospective and 
observational study was conducted for aperiod of nine 
months in the department of Medicine, at BLDEA’S Shri B. 
M. Patil Medical College Hospital and Research Centre, 
Vijayapur, after obtaining the institutional ethical 
committee clearance. The patients admitted to medicine 
wards were screened according to inclusion and exclusion 
criteria and 120 patients were finally selected for the 
study. 
Inclusion criteria 
 Inpatients in general medicine wards. 
 Patients of age above 18 years.  
 Patients admitted to CCU and ICU. 
 Patients who are willing to participate in the study. 
Exclusion Criteria: 
 Outpatients. 
 Inpatients other than general medicine wards, ICU, 
CCU. 
 Patients of OBG and Pediatrics.  
 Patients who are not willing to participate in the 
study. 
Data collection: 
Data extracted from the case files by using data collection 
form (includes demographic data, chief complaints , social 
history , side effects, past medical history and past 
medication history, laboratory details, diagnosis and 
treatment chart). And DRP’S were documented in a 
structured patient data collection form design according to 
the study objectives. 
Statistical analysis: 
The data were expressed in simple mathematics and 
multiple responses were reported in terms of percentages. 
The graphs and Table were generated using the Microsoft 
excel sheet.  
RESULTS 
Among the 120 selected patients, 79 were male patients 
(65.83%) and 41 were female patients (34.16%), more 
number of patients (35) were between the age group of 55-
64 (29.16%) of which 27 were males & 8 were females, 
and very less number of patients (6) were between the age 
group 85-94 (5%) of which all the 6 were male.  
Hypertension is the most commonest and dominant 
disorder, which affected 47 patients among 120 patients, in 
which 30 were male (25%) and 17 were female (14.16%), 
it constitutes 39.16% of the total study population. 
Most common risk factor is HTN followed with smoking 
and diabetes, which is predominant in 30 males (25%), 15 
females (12.5%) and totally 45 patients (37.5%) of the 
study.  
Diuretics were the most often prescribed drugs in the 
study in which furosemide(69) was pescribed frequently 
followed by toresemide(32) and spiranolactone(17). Oral 
anti-coagulants were the second most prescribed drugs in 
which asprin(57), clopidogrel9(27) was more frequently 
prescribed. Ramipril was the frequently prescribed drug in 
ACE inhibitors. Amlodipine(34) was frequently prescribed 
in CCBs and propronolol(17) in BBs 
The most often prescribed pattern adopted in CVD is Dual 
therapy, it is most frequently (50) used therapy (41.66%) 
and quadruple therapy is less frequently (6) used (6.5%). 
The diuretics and calcium channel blocker combination 
were maximally prescribed class of drugs as a dual 
therapy. 
A total of 47 drug-drug interactions were found, among 12 
were major, 15 were moderate and 20 were minor 
interactions. 3 interacting pairs of DDIs were 
predominantly seen in the study of which 
clopidogrel+rabeprazole was the mostly encountered 
interacting pair. 
Management of the DDIs was done in the study in which 
one of the drug in the two interacting pairs has been 
replaced with the other alternative drug 
Clinical pharmacist has intervened with the help of other 
health care professionals in order to reduce the risk factor 
and drug-drug interactions for the betterment of the 
patient.  
DISCUSSION 
A Prospective observational study was conducted on 
prescribing pattern of drugs and pharmacist/medical 
intervention in cardiovascular diseases in medicine 
department for a period of nine months.  Total 120 study 
subjects were included in the study, out of which 79 were 
male patients constituting 65.83% and 41 were female 
patients constituting 34.16%.  Males are more in number 
when compared to females (Table 1) 
According to the study more number of patients (35) were 
between the age group of 55-64 constituting 29.16% of 
which 27 were males & 8 were females, and less number of 
patients (6) were between the age group 85-94 
constituting 5% of which all the 6 were male.(Table 2). 
Hypertension is the most dominant disease, which affected 
47 patients in which 30 were male constituting 25% and 
17 were female constituting 14.16% which is similar to the 
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study conducted by the Md. Abdul Muhit et.al, on 
Cardiovascular disease prevalence and prescription 
patterns at a tertiary level hospital in Bangladesh.1IHD 
patients (23) & ACS patients(19) were the second 
predominantly observed diseases and a very rare cases of 
SVT(1),CVA(1),and DCM(1) were observed in the study. 
(Table 3). 
 
Table 1: Gender distribution 
. 
 
 
 
Table 2: Age distribution 
SI. No. Age group 
(in years) 
Male Female Total 
N % N % N % 
     1      35-44 13 10.83 2 1.66 15 12.49 
     2      45-54 14 11.66 7 5.83 21 17.49 
     3      55-64 27 22.5 8 6.66 35 29.16 
     4     65-74 14 11.66 14 11.66 28 23.32 
     5     75-84 5 4.16 10 8.33 15 12.49 
     6      85-94 6 5 0 0 6 5 
  Total 79 41 120 
 
Table 3: Different types of CVD In male and female 
SI. No. Disease  Male  % Female  % Total   % 
1 Hypertension  30 25 17 14.16 47 39.16 
2 Angina  8 6.66 3 2.5 11 9.16 
3 MI 6 5 6 5 12 10 
4 ACS  15 12.5 4 3.33 19 15.83 
5 IHD  12 10 11 9.16 23 19.16 
6 Stroke  5 4.16 0 0 5 4.16 
7 Dialated Cardiomyopathy  1 0.83 0 0 1 0.83 
8 Supra ventricular tachycardia  1 0.83 0 0 1 0.83 
9 Cerebrovascular accident  1 0.83 0 0 1 0.83 
Total  79 65.83 41 34.16 120 99.99 
 
 
The most commonly found risk factor in the study is HTN, 
which is predominant in 30 males constituting 25%, 15 
females constituting 12.5% and totally 45 patients 
constituting 37.5% of the study which is contradicting with 
the study conducted by Peter Tanuseputro et.al, on Risk 
factors for cardiovascular disease in Canada.14 The second 
common risk factor was smoking that was observed in 25 
malesubjects and diabetes is also the other risk factor that 
was observed in 35 study subjects. The least observed risk 
factor is the family history (hereditary) that was observed 
in 5 study subjects.(Table 4) 
Diuretics were the most often prescribed drugs in the 
study in which furosemide(69) was pescribed frequently 
followed by toresemide(32) and spiranolactone(17). Oral 
anti-coagulants were the second most prescribed drugs in 
which asprin(57), clopidogrel9(27) was more frequently 
prescribed. Ramipril was the frequently prescribed drug in 
ACE inhibitors. Amlodipine(34) was frequently prescribed 
in CCBs and propronolol(17) in BBs.(Table 5) 
Subjects in the study were treated with 4 different types of 
therapy(based on no. of drugs prescribed ) like mono, dual, 
triple and quadruple therapy in which more patients(50)  
received dual therapy constituting 41.66% followed by  
triple therapy (39) and mono therapy (25). Quadruple 
therapy was given in very less study subjects(6) as show in 
the (Table 6). 
 
Table 4: Common risk factors in CVD 
SI. No Risk Factors Male % Female % Total % 
1 HTN 30 25 15 12.5 45 37.5 
2 Smoking 25 20.83 0 0 25 20.83 
3 Diabetes 17 14.16 18 15 35 29.6 
4 Age 6 5 4 3.33 10 8.33 
5 Family history 3 2.5 2 1.66 5 4.16 
 Total 81  39  120  
 
 
SI. No. Gender No. of Patients Percentage 
1 Male 79 65.83 
2 Female 41 34.16 
Total 120 100% 
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Table 5: Class of drugs prescribed with respect to their individual drugs 
SI. No. Drug Class  Individual Class  No. of Subjects 
1 Diuretics  
 
Furosemide, 69 
Toresemide 32 
Spiranolactone 17 
2 ACE inhibitors  Captopril, 12 
Ramipril  46 
3 Beta blockers  Metprolol, 13 
Propranolol 15 
4 ARBs  Losartan, 7 
Telimisartan 3 
5 Oral anti-coagulants  Asprin, 57 
Clopidogrel, 27 
Warfarin 16 
Heparin, 2 
Enoxaparin. 2 
6  Nitrates  ISMN 10 
ISDN  5 
7 CCBs  Amlodipine, 34 
Nifedipine 13 
 
Table 6: Type of prescribing pattern in CVD 
SI. No Type of Therapy No. of patients % 
1 Mono 25 20.83 
2 Dual 50 41.66 
3 Triple 39 32.5 
4 Quadruple 6 6.5 
 Total 120 100 
 
According to the study the most commonly prescribed dual 
drug combination is diuretics with CCBs(20) followed by 
ACE-I with diuretics (15) which is similar to the study 
conducted by OlusegunAdesola Busari1et. al, on 
Prescribing pattern and utilization of antihypertensive 
drugs and blood pressure control in adult patients with 
systemic hypertension in a rural tertiary hospital in 
Nigeria.15(Table 7) 
The present study identified the DDIs among patients 
admitted to cardiac unit of general medicine ward, a total 
of 47 DDIs were identified among 120 study subjects. 
Major DDIs were encountered for 12 times, moderate DDIs 
were encountered for 15 times and minor DDIs  for 20 
times.(Table 8) 
Out of 12 major DDIs Clopidogrel +rabeprazole(6) is the 
most common inetracting pair followed by Furosemide 
+gentamycin (4) &Metronidazole+warfarin(2) of this 
study. Management of the DDIs was done in the study in 
which one of the drug in the two interacting pairs has been 
replaced with the other alternative drug (Table 9) 
 
Table 7: Dual therapy 
SI. No. Name of the Drug Class No. of Times Prescribed % 
1 Diuretics+CCB 20 40% 
2 ACE-I+Diuretics 15 30% 
3 AC+BB 2 4% 
4 ACE-I+Nitrates 5 10% 
5 CCB+ACE-I 8 16% 
 Total 50 100 
 
Table 8: Drug-drug interactions 
SI. No. DDI No. of Times Encountered % 
1 Major 12 25.31 
2 Moderate 15 31.91 
3 Minor 20 42.55 
 Total 47  
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Table 9: Pharmacist intervention in management of major DDIs 
SI. No. Interacting pair Effect Management No. of Patients 
Recovered 
1. Clopidogrel+Rabeprazole Decreased action of Clopidogrel PPIs were replaced with H2 
antihistamines(Ranitidine) 
6 
2. Furosemide+Gentamicin Addittive drug effects 
Ototoxicity, Nephrotoxicity 
Alternate medication is 
given(Amoxicillin) 
4 
3. Metronidazole+Warfarin Increased bleeding Alternate antibiotic is 
used(Tinidazole) 
2 
 
CONCLUSION 
The present study explores the common risk factors 
involved in CVD and prevalence of CVD with age and sex. 
The study reveals the prescribing pattern (dual therapy) 
drugs and common class of drugs prescribed for the 
management of CVD. Clinical pharmacist role play an 
important role in reducing the risk factors, drug-drugs 
interactions and drug related problems. The study 
provides the benefits of the presence of clinical pharmacist 
in a hospital setting, in order to prevention of medication 
errors; provide the expertise pharmacotherapy and better 
management of drug therapy based on patients specific 
factors.  All together influence the improvement in patient 
compliance, safety, level of care, better control of risk 
factor and health care cost, thus the present study justify 
the need for active collaboration between clinical 
pharmacist, physician and other health care professionals 
in the better management of CVDs. 
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